Condition: ST-segment Elevation Myocardial Infarction (STEMI) · Diabetes Mellitus · Insulin Resistance · Sponsor: German Diabetes Center
The aim of the prospective observational DISTEMI-Study in people with and without Diabetes mellitus (DI) after new onset of ST-Segment Elevation Myocardial Infarction (STEMI) aged 18-80 years at inclusion into the study is to characterize in detail the clinical, metabolical, immunological and vascular phenotype, investigate the interplay between myocardial remodelling and the metabolic phenotype, monitor the progression of the disease and compare the phenotype of STEMI people with diabetes mellitus to people with prediabetes and glucose tolerant people.
This description comes directly from the study's public registry record.
Michael Roden, Prof., MD · +49-211-3382-0 · michael.roden@ddz.de
Clara Möser, MD · +49-211-3382-0 · clara.moeser@ddz.de
Always discuss trial participation with your own doctor first.
| German Diabetes Center | Düsseldorf, North Rhine-Westphalia, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05046483